Clinical pharmacology and pharmacokinetics of amprenavir.
about
Structural and Thermodynamic Basis of Amprenavir/Darunavir and Atazanavir Resistance in HIV-1 Protease with Mutations at Residue 50An assay to monitor HIV-1 protease activity for the identification of novel inhibitors in T-cellsStructural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 proteaseEffects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers.Preclinical pharmacology and pharmacokinetics of GW433908, a water-soluble prodrug of the human immunodeficiency virus protease inhibitor amprenavir.Pregnane X receptor mediates dyslipidemia induced by the HIV protease inhibitor amprenavir in mice.Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics.Enthalpy screen of drug candidates.Population pharmacokinetic modeling and simulation of amprenavir following fosamprenavir/ritonavir administration for dose optimization in HIV infected pediatric patients.Effects of didanosine formulations on the pharmacokinetics of amprenavir.Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients.
P2860
Q27676079-9B47EF98-42FE-4B41-AA43-5D508C59D679Q28474218-9D4C9462-8EC2-45B7-BD49-6F1CC16FDCA4Q34526179-0A7AD534-B6FE-41A1-A8C7-6E0364AB6702Q35196656-A0843061-2679-411F-923D-B651A2895917Q36491065-31E20CB4-3D8A-4B9B-9AED-5259645D9834Q36852528-CF6E1FCF-7BCB-4BCE-B2A7-EEF4BD0E4CF0Q37866298-8B0791AA-C9C1-442F-BBED-F389AF56D750Q40604721-C22B6305-A314-4163-A862-B9C047CC6C85Q41720226-2756ECF4-7EF7-4A37-A7B7-194720D64019Q44528623-61537BD7-01DC-4CD9-8712-F97A023662A1Q44965782-C4A06207-18D5-43A7-BABB-2F11096A704D
P2860
Clinical pharmacology and pharmacokinetics of amprenavir.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical pharmacology and pharmacokinetics of amprenavir.
@ast
Clinical pharmacology and pharmacokinetics of amprenavir.
@en
Clinical pharmacology and pharmacokinetics of amprenavir.
@nl
type
label
Clinical pharmacology and pharmacokinetics of amprenavir.
@ast
Clinical pharmacology and pharmacokinetics of amprenavir.
@en
Clinical pharmacology and pharmacokinetics of amprenavir.
@nl
prefLabel
Clinical pharmacology and pharmacokinetics of amprenavir.
@ast
Clinical pharmacology and pharmacokinetics of amprenavir.
@en
Clinical pharmacology and pharmacokinetics of amprenavir.
@nl
P2860
P356
P1476
Clinical pharmacology and pharmacokinetics of amprenavir.
@en
P2093
Brian M Sadler
Daniel S Stein
P2860
P304
P356
10.1345/APH.10423
P407
P577
2002-01-01T00:00:00Z